LENZ Therapeutics (LENZ) Q3 2025 Results Filing

LENZ Therapeutics filed a Form 8-K on November 5, 2025, primarily to announce financial results.

• Item Reported: Item 2.02 (Results of Operations and Financial Condition).
• Reporting Period: Financial results are for the quarter ended September 30, 2025.
• Key Takeaway: The actual performance metrics are contained in the furnished press release (Exhibit 99.1).
• LENZ confirms its status as an Emerging Growth Company.

Investors must review Exhibit 99.1 for details on revenue, expenses, and cash position f